Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
Open Access
- 13 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 814953
Abstract
Background:The pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) and mechanisms underlying different responses to systemic glucocorticoids (GC) remain unclear. The major aim of this study was to explore the transcriptomic and oxidative lipidomic signatures and the effects of GC in patients with different clinical responses.Methods:Nasal polyp biopsies were obtained before and after 14-day oral GC treatment from 16 patients with CRSwNP, and normal nasal mucosa specimens were collected from 12 control subjects. RNA sequencing and oxidative lipidomics were performed, and differential gene expression analysis was conducted in the Responder and Non-responder groups at baseline and after treatment.Results:In the Responder group, GC significantly improved clinical symptoms and reduced tissue eosinophil infiltration. Meanwhile, GC led to a pronounced transcriptomic reversion with robust suppression of inflammatory responses and abnormal metabolism of extracellular matrix, as well as restoration of cilia function. However, non-responders were mainly characterized by epithelial hyperplasia and keratinization, with much less transcriptomic improvement after GC treatment. Higher expression of type 2 inflammatory molecules (CCL13, IGHE, CCL18, CCL23, CCR3,andCLC) with lower levels ofLACRT, PPDPFL, DES, C6, MUC5B,andSCGB3A1were related to a stronger clinical response to GC. Besides decreased prostaglandins and increased leukotrienes, increased dysregulation in other oxylipid mediators derived from polyunsaturated fatty acids was determined in nasal polyps, which was ameliorated by GC treatment.Conclusion:Systemic GC exert anti-inflammatory effects, improve tissue remodeling, restore cilia function, and ameliorate dysregulation of oxylipid mediator pathway in CRSwNP. GC-responders exhibited different transcriptomic signatures from non-responders.Keywords
This publication has 67 references indexed in Scilit:
- Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2013
- Acquired Cilia Dysfunction in Chronic RhinosinusitisAmerican Journal of Rhinology & Allergy, 2012
- The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polypsAllergy, 2011
- Role of p63/p73 in epithelial remodeling and their response to steroid treatment in nasal polyposisJournal of Allergy and Clinical Immunology, 2011
- Oral steroids enhance epithelial repair in nasal polyposis via upregulation of the AP-1 gene networkThorax, 2009
- Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus diseaseJournal of Allergy and Clinical Immunology, 2008
- Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroidsProceedings of the National Academy of Sciences, 2007
- Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposisJournal of Allergy and Clinical Immunology, 2005
- Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polypsJournal of Allergy and Clinical Immunology, 2004
- Bronchial ciliogenesis and oral steroid treatment in patients with asthmaRespiratory Medicine, 1988